免疫抑制药物所允许的供体细胞嵌合现象：器官移植的新视角。
Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation.
作者信息
Starzl T E, Demetris A J, Murase N, Thomson A W, Trucco M, Ricordi C
机构信息
Dept of Surgery, University of Pittsburgh Health Science Center, PA 15213.
出版信息
Immunol Today. 1993 Jun;14(6):326-32. doi: 10.1016/0167-5699(93)90054-o.
Abstract
One line of thought in organ transplantation feels that immunosuppressive drugs can lead to tolerance induction by allowing a previously unrecognized common mechanism of cell migration and microchimerism to occur, persist, and in some cases, become drug independent. It has been recognized that there is a spectrum of susceptibility of different organs to cellular rejection and that the variable ability of these organs to induce donor-specific nonreactivity reflects their comparative content of migratory leukocytes. Here, Thomas Starzl and colleagues discuss how many of the enigmas of transplantation immunology can be explained by this chimerism.
摘要
器官移植领域的一种观点认为，免疫抑制药物可通过促使一种此前未被认识的细胞迁移和微嵌合现象的共同机制出现、持续存在，且在某些情况下变得不依赖药物，从而诱导免疫耐受。人们已经认识到，不同器官对细胞排斥的易感性存在差异，这些器官诱导供体特异性无反应性的能力各不相同，这反映了它们迁移白细胞的相对含量。在此，托马斯·斯塔兹尔及其同事讨论了这种嵌合现象如何能够解释移植免疫学中的诸多谜团。
相似文献
1
Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation.免疫抑制药物所允许的供体细胞嵌合现象：器官移植的新视角。
Immunol Today. 1993 Jun;14(6):326-32. doi: 10.1016/0167-5699(93)90054-o.
2
Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation.免疫抑制药物所允许的供体细胞嵌合现象：器官移植的新视角。
Trends Pharmacol Sci. 1993 May;14(5):217-23. doi: 10.1016/0165-6147(93)90212-3.
3
Xenobiotics, chimerism and the induction of tolerance following organ transplantation.异种生物、嵌合体与器官移植后的耐受诱导
Ther Immunol. 1994 Jun;1(3):153-64.
4
Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts.通过非致死性预处理方案实现的混合嵌合体可诱导对肺同种异体移植物的供体特异性耐受。
J Surg Res. 2008 May 15;146(2):289-97. doi: 10.1016/j.jss.2007.07.017. Epub 2007 Aug 23.
5
6
[Is immune tolerance just a chimera?].免疫耐受只是一种幻想吗？
G Ital Nefrol. 2008 May-Jun;25(3):272.
7
Microchimerism, GVHD, and tolerance in solid organ transplantation.实体器官移植中的微嵌合体、移植物抗宿主病与免疫耐受
Transfusion. 2001 Mar;41(3):419-26. doi: 10.1046/j.1537-2995.2001.41030419.x.
8
Chimerism after whole organ transplantation: its relationship to graft rejection and tolerance induction.全器官移植后的嵌合体：其与移植排斥和免疫耐受诱导的关系。
Curr Opin Nephrol Hypertens. 1994 Nov;3(6):589-95. doi: 10.1097/00041552-199411000-00005.
9
Apoptotic Donor Cells in Transplantation.移植中的凋亡供体细胞。
Front Immunol. 2021 Feb 25;12:626840. doi: 10.3389/fimmu.2021.626840. eCollection 2021.
引用本文的文献
1
Combined Organ Transplantation in Patients with Advanced Liver Disease.联合器官移植治疗晚期肝病患者。
Semin Liver Dis. 2024 Aug;44(3):369-382. doi: 10.1055/s-0044-1788674. Epub 2024 Jul 25.
2
Establishment of Chimerism and Organ Transplant Tolerance in Laboratory Animals: Safety and Efficacy of Adaptation to Humans.嵌合体的建立与实验动物器官移植耐受：适应人体的安全性和有效性。
Front Immunol. 2022 Feb 10;13:805177. doi: 10.3389/fimmu.2022.805177. eCollection 2022.
3
Long-term survival with mixed chimerism in patients with AML and MDS transplanted after conditioning with targeted busulfan, fludarabine, and thymoglobulin.在接受靶向白消安、氟达拉滨和抗胸腺球蛋白预处理后，AML 和 MDS 患者混合嵌合体的长期生存。
Bone Marrow Transplant. 2022 Feb;57(2):198-206. doi: 10.1038/s41409-021-01518-0. Epub 2021 Nov 5.
4
Immunological Consequences of Exposure to Foreign Antigens.接触外来抗原的免疫后果。
Front Immunol. 2021 Apr 15;12:638435. doi: 10.3389/fimmu.2021.638435. eCollection 2021.
5
Mechanisms of Tolerance Induction by Hematopoietic Chimerism: The Immune Perspective.造血嵌合体诱导耐受的机制：免疫观点。
Stem Cells Transl Med. 2017 Mar;6(3):700-712. doi: 10.1002/sctm.16-0358. Epub 2017 Jan 3.
6
Banking on iPSC--is it doable and is it worthwhile.iPSC 银行——是否可行，是否值得。
Stem Cell Rev Rep. 2015 Feb;11(1):1-10. doi: 10.1007/s12015-014-9574-4.
7
Hematopoietic cell transplantation for tolerance induction.用于诱导耐受的造血细胞移植。
Cytotechnology. 1998 Jan;26(1):1-4. doi: 10.1023/A:1007902711633.
8
Human liver xenotransplantation.人类肝脏异种移植
Xeno. 1993 Sep;1(1):4-7.
9
Kidney/Bone Marrow Transplantation.肾/骨髓移植
Dial Transplant. 1996;25(5):282-287.
10
The basis of allograft acceptance.同种异体移植接受的基础。
Forum (Genova). 1997;7(Suppl 6):7-18.
本文引用的文献
1
2
IMMUNOLOGIC STUDIES IN HUMAN ORGAN TRANSPLANTATION. I. OBSERVATION AND CHARACTERIZATION OF SUPPRESSED CUTANEOUS REACTIVITY IN UREMIA.人类器官移植中的免疫学研究。I. 尿毒症患者皮肤反应性抑制的观察与特征分析
J Exp Med. 1964 May 1;119(5):727-42. doi: 10.1084/jem.119.5.727.
3
THE REVERSAL OF REJECTION IN HUMAN RENAL HOMOGRAFTS WITH SUBSEQUENT DEVELOPMENT OF HOMOGRAFT TOLERANCE.人类肾移植排斥反应的逆转及随后同种移植耐受性的发展
Surg Gynecol Obstet. 1963 Oct;117:385-95.
4
Homotransplantation of multiple visceral organs.多个内脏器官的同种移植
Am J Surg. 1962 Feb;103:219-29. doi: 10.1016/0002-9610(62)90491-9.
5
Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease.IV型糖原贮积病和1型戈谢病肝移植后的嵌合体现象。
N Engl J Med. 1993 Mar 18;328(11):745-9. doi: 10.1056/NEJM199303183281101.
6
Graft-versus-host disease after brown Norway-to-Lewis and Lewis-to-Brown Norway rat intestinal transplantation under FK506.在FK506作用下，棕色挪威大鼠到刘易斯大鼠以及刘易斯大鼠到棕色挪威大鼠肠道移植后的移植物抗宿主病
Transplantation. 1993 Jan;55(1):1-7. doi: 10.1097/00007890-199301000-00001.
7
Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells.通过添加供体品系树突状细胞恢复去除过客细胞的肾移植异体移植物的免疫原性。
J Exp Med. 1982 Jan 1;155(1):31-41. doi: 10.1084/jem.155.1.31.
8
Demonstration and characterization of Ia-positive dendritic cells in the interstitial connective tissues of rat heart and other tissues, but not brain.大鼠心脏及其他组织（而非脑）的间质结缔组织中Ia阳性树突状细胞的证实与特性研究。
J Exp Med. 1981 Aug 1;154(2):347-61. doi: 10.1084/jem.154.2.347.
9
Idiotypic networks and other preconceived ideas.独特型网络及其他先入之见。
Immunol Rev. 1984 Jun;79:5-24. doi: 10.1111/j.1600-065x.1984.tb00484.x.
10
Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts.用同基因加异基因或异种骨髓进行重建可导致对同种异体移植物或异种移植物的特异性接受。
Nature. 1984;307(5947):168-70. doi: 10.1038/307168a0.
Zotero 插件